Sharma Arti B, Knott E Marty, Bi Jian, Martinez Rodolfo R, Sun Jie, Mallet Robert T
Department of Integrative Physiology, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107-2699, USA.
Resuscitation. 2005 Jul;66(1):71-81. doi: 10.1016/j.resuscitation.2004.12.016.
Severe depletion of myocardial energy and antioxidant resources during cardiac arrest culminates in electromechanical dysfunction following recovery of spontaneous circulation (ROSC). A metabolic fuel and natural antioxidant, pyruvate augments myocardial energy and antioxidant redox states in parallel with its enhancement of contractile performance of stunned and oxidant-challenged hearts. This study tested whether pyruvate improves post-arrest cardiac function and metabolism. Beagles were subjected to 5 min cardiac arrest and 5 min open-chest cardiac compression (OCCC: 80 compressions min(-1); aortic pressure 60-70 mmHg), then epicardial dc countershocks (5-10 J) were applied to restore sinus rhythm. Pyruvate was infused i.v. throughout OCCC and the first 25 min ROSC to a steady-state arterial concentration of 3.6+/-0.2 mM. Control experiments received NaCl infusions. Phosphocreatine phosphorylation potential (approximately PCr) and glutathione/glutathione disulfide ratio (GSH/GSSG), measured in snap-frozen left ventricle, indexed energy and antioxidant redox states, respectively. In control experiments, left ventricular pressure development, dP/dt and carotid flow initially recovered upon defibrillation, but then fell 40-50% by 3 h ROSC. ST segment displacement in lead II ECG persisted throughout ROSC. Approximately PCr collapsed and GSH/GSSG fell 61% during arrest. Both variables recovered partially during OCCC and completely during ROSC. Pyruvate temporarily increased approximately PCr and GSH/GSSG during OCCC and the first 25 min ROSC and enhanced pressure development, dP/dt and carotid flow at 15-25 min ROSC. Contractile function stabilized and ECG normalized at 2-3 h ROSC, despite post-infusion pyruvate clearance and waning of its metabolic benefits. In conclusion, intravenous pyruvate therapy increases energy reserves and antioxidant defenses of resuscitated myocardium. These temporary metabolic improvements support post-arrest recovery of cardiac electromechanical performance.
心脏骤停期间心肌能量和抗氧化资源的严重消耗最终导致自主循环恢复(ROSC)后出现机电功能障碍。丙酮酸作为一种代谢燃料和天然抗氧化剂,在增强顿抑心肌和受氧化剂攻击心肌的收缩性能的同时,可增强心肌能量和抗氧化氧化还原状态。本研究测试了丙酮酸是否能改善心脏骤停后的心脏功能和代谢。对小猎犬进行5分钟的心脏骤停和5分钟的开胸心脏按压(OCCC:80次/分钟;主动脉压力60 - 70 mmHg),然后进行心外膜直流电除颤(5 - 10 J)以恢复窦性心律。在整个OCCC期间及ROSC的最初25分钟内静脉输注丙酮酸,使动脉浓度达到稳态的3.6±0.2 mM。对照实验输注生理盐水。在速冻的左心室中测量的磷酸肌酸磷酸化电位(约PCr)和谷胱甘肽/谷胱甘肽二硫化物比率(GSH/GSSG)分别代表能量和抗氧化氧化还原状态。在对照实验中,除颤后左心室压力上升、dP/dt和颈动脉血流最初有所恢复,但在ROSC 3小时时下降了40 - 50%。II导联心电图的ST段移位在整个ROSC期间持续存在。心脏骤停期间约PCr崩溃,GSH/GSSG下降61%。这两个变量在OCCC期间部分恢复,在ROSC期间完全恢复。丙酮酸在OCCC期间及ROSC的最初25分钟内使约PCr和GSH/GSSG暂时升高,并在ROSC 15 - 25分钟时增强压力上升、dP/dt和颈动脉血流。尽管输注后丙酮酸清除且其代谢益处减弱,但收缩功能在ROSC 2 - 3小时时稳定,心电图恢复正常。总之,静脉注射丙酮酸疗法可增加复苏后心肌的能量储备和抗氧化防御能力。这些暂时的代谢改善支持心脏骤停后心脏机电性能的恢复。